Publications by authors named "An Coosemans"

34Publications

Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer.

Transl Oncol 2020 Mar 4;13(3):100743. Epub 2020 Mar 4.

Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tranon.2020.01.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058407PMC
March 2020

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study.

Cells 2020 01 27;9(2). Epub 2020 Jan 27.

ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells9020305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072171PMC
January 2020

Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?

Curr Oncol Rep 2020 01 29;22(2):12. Epub 2020 Jan 29.

Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-0864-5DOI Listing
January 2020

Trial watch: dendritic cell vaccination for cancer immunotherapy.

Oncoimmunology 2019 18;8(11):e1638212. Epub 2019 Jul 18.

Cell Death Research & Therapy (CDRT) unit, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2019.1638212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791419PMC
July 2019

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.

Front Immunol 2019 4;10:1273. Epub 2019 Jun 4.

ImmunOvar Research Group, Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.01273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558014PMC
October 2020

Influence of CA125, platelet count and neutrophil to lymphocyte ratio on the immune system of ovarian cancer patients.

Gynecol Oncol 2018 07 9;150(1):31-37. Epub 2018 May 9.

Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Gynecology and Obstetrics, UZ Leuven, Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183089
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.05.004DOI Listing
July 2018

Orientation of Preclinical Research in Ovarian Cancer.

Int J Gynecol Cancer 2017 10;27(8):1579-1586

*Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven; and †Department of Oncology, Laboratory for Tumor Immunology and Immunotherapy, ImmunOvar Research Group, ‡Department of Cellular and Molecular Medicine, Laboratory for Cell Death Research and Therapy, and §Department of Oncology, Laboratory of Gynaecological Oncology, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
https://ijgc.bmj.com/lookup/doi/10.1097/IGC.0000000000001053
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000001053DOI Listing
October 2017

Ovarian cancer and the immune system.

Gynecol Oncol Rep 2017 Feb 6;19:57-58. Epub 2017 Jan 6.

Department of Gynaecology and Obstetrics, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium; Department of Oncology, Laboratory for Tumor Immunology and Immunotherapy, ImmunOvar Research Group, KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2017.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247278PMC
February 2017

mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70).

Methods Mol Biol 2016 ;1428:277-83

Laboratory of Gynecologic Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3625-0_18DOI Listing
December 2017

Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course.

Oncoimmunology 2016 Apr 21;5(4):e1111505. Epub 2015 Dec 21.

Department of Gynecology and Obstetrics, UZ Leuven, Leuven, Belgium; Department of Oncology, Laboratory of Gynecologic Oncology, ImmunOvar Research Group, KU Leuven, Leuven Cancer Institute, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1111505DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839325PMC
April 2016

Morcellation and risk of malignancy in presumed ovarian fibromas/fibrothecomas.

Lancet Oncol 2016 Mar 2;17(3):273-274. Epub 2016 Mar 2.

Department of Development and Regeneration and Department of Oncology, KU Leuven, Leuven, Belgium; Department of Gynaecology and Obstetrics and Leuven Cancer Institute, University Hospitals KU Leuven, Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)00022-XDOI Listing
March 2016

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer.

J Immunother Cancer 2015 15;3:57. Epub 2015 Dec 15.

Department of Gynaecology and Obstetrics, UZ Leuven, Leuven, Belgium ; Department of Oncology, Laboratory of Gynaecologic Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0102-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678634PMC
December 2015

Dendritic cell immunotherapy in uterine cancer.

Hum Vaccin Immunother 2014 ;10(7):1822-7

a Department of Oncology; Leuven Cancer Institute; KU Leuven; Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.28716DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186030PMC
July 2015

Dendritic cell-based immunotherapy in ovarian cancer.

Oncoimmunology 2013 Dec 6;2(12):e27059. Epub 2013 Nov 6.

Department of Microbiology and Immunology; KU Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.27059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913669PMC
December 2013

Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.

Anticancer Res 2013 Dec;33(12):5495-500

KU Leuven, Laboratory of Pediatric Immunology, Onderwijs & Navorsing 1, Herestraat 49 bus 811, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
December 2013

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.

Anticancer Res 2013 Sep;33(9):3855-9

KU Leuven, Laboratory of Pediatric Immunology, Onderwijs & Navorsing 1, Herestraat 49 bus 811, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
September 2013

Screening for uterine tumours.

Best Pract Res Clin Obstet Gynaecol 2012 Apr 9;26(2):257-66. Epub 2011 Nov 9.

Department of Obstetrics and Gynecology, University Hospitals, Herestraat 49, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpobgyn.2011.08.002DOI Listing
April 2012

Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma.

Int J Gynecol Cancer 2011 Feb;21(2):302-8

Laboratory of Experimental Gynecology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e318207cab5DOI Listing
February 2011

Clinical management of uterine sarcomas.

Lancet Oncol 2009 Dec;10(12):1188-98

Leuven Cancer Institute, Gynaecological Oncology, University Hospital Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70226-8DOI Listing
December 2009

Clinical outcome of ET-743 (Trabectedin; Yondelis) in high-grade uterine sarcomas: report on five patients and a review of the literature.

Int J Gynecol Cancer 2009 Feb;19(2):245-8

Division of Gynecological Oncology, Department of Obstetrics and Gynecology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e31819c0f59DOI Listing
February 2009

Wilms' tumor gene 1 (WT1) in endometrial carcinoma.

Gynecol Oncol 2008 Dec 16;111(3):502-8. Epub 2008 Oct 16.

Laboratory of Experimental Gynaecology, Katholieke Universiteit Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.08.032DOI Listing
December 2008

Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study.

Fertil Steril 2009 Apr 22;91(4 Suppl):1441-4. Epub 2008 Aug 22.

Department of Obstetrics and Gynaecology, Experimental Laboratory of Gynaecology, UZ Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.fertnstert.2008.06.042DOI Listing
April 2009